Market Newsdesk

A team of 400+ inspectors are ready and waiting to inspect your fleet today

VANCOUVER, BC, April 7, 2021 /PRNewswire/ – Ritchie Bros. inspects tens of thousands of equipment items each month, in preparation for sale in one of its numerous sales solutions, including live/online auctions with Ritchie Bros. Auctioneers, weekly online marketplaces at IronPlanet, and a daily reserved solution in Marketplace-E. The company also inspects tens of thousands of additional items to support customers for lease returns, financing, trade-ins, repossessions, private sale, asset verification, and more. All in all, Ritchie Bros. Inspection Services and its 400+ team members completed more than 600,000 equipment inspections in 2020, taking over 15 million photos and analyzing hundreds of thousands of oil samples in its in-house fluid analysis lab.     

“Ritchie Bros. is much more than auctions today. We offer a wealth of services, insights, and transaction solutions to help customers better manage and dispose of commercial assets,” said Logan Mellott, Vice President, Commercial Operations, Ritchie Bros. “Ritchie Bros. inspections are needed by customers every day and we believe we have the best team and technology in the industry, uniquely positioning us to innovate and develop targeted services and solutions to meet the increasingly-sophisticated needs of our customer base.”

With a wealth of new services and insights in recent years, Ritchie Bros. launched an end-to-end asset management and disposition tool called RB Asset Solutions in 2019. It includes a FREE inventory management system where customers can upload their fleet with photos and detailed info. From RB Asset Solutions, customers can also request an inspection, appraisal, and other services with a click of button.

“Inspections are needed throughout the lifecycle of an asset, not just prior to sale,” added Mr. Mellott. “We want our customers to know that we are here to help them all year round. With RB Asset Solutions, Inspection Services, and the complete suite of tools we offer, Ritchie Bros. is here to help with your success.”

For more information about Ritchie Bros. Inspection Services, contact [email protected].

About Ritchie Bros.:

Established in 1958, Ritchie Bros. (NYSE and TSX: RBA) is a global asset management and disposition company, offering customers end-to-end solutions for buying and selling used heavy equipment, trucks and other assets. Operating in a number of sectors, including construction, transportation, agriculture, energy, oil and gas, mining, and forestry, the company’s selling channels include: Ritchie Bros. Auctioneers, the world’s largest industrial auctioneer offers live auction events with online bidding; IronPlanet, an online marketplace with featured weekly auctions and providing the exclusive IronClad Assurance® equipment condition certification; Marketplace-E, a controlled marketplace offering multiple price and timing options; Mascus, a leading European online equipment listing service; and Ritchie Bros. Private Treaty, offering privately negotiated sales. The Company’s suite of solutions also includes Ritchie Bros. Asset Solutions and Rouse Services LLC, which together provides a complete end-to-end asset management, data-driven intelligence and performance benchmarking system. Ritchie Bros. also offers sector-specific solutions including GovPlanet, TruckPlanet, and Kruse Energy, plus equipment financing and leasing through Ritchie Bros. Financial Services. For more information about Ritchie Bros., visit RitchieBros.com.

Photos and video for embedding in media stories are available at rbauction.com/media. 

View original content:http://www.prnewswire.com/news-releases/ritchie-bros-inspection-services-completes-600-000-equipment-and-truck-inspections-in-2020–301263551.html

SOURCE Ritchie Bros.

NORTH CANTON, Ohio, April 7, 2021 /PRNewswire/ — The Timken Company (NYSE: TKR; www.timken.com), a global industrial leader in engineered bearings and power transmission products, will release its first-quarter 2021 financial results on Wednesday, April 28, prior to the opening of the New York Stock Exchange. The company will host a conference call that day to discuss its financial performance with investors and securities analysts. The financial results and conference call materials will be available online at http://investors.timken.com.

About The Timken Company

The Timken Company (NYSE: TKR; www.timken.com) designs a growing portfolio of engineered bearings and power transmission products. With more than a century of knowledge and innovation, we continuously improve the reliability and efficiency of global machinery and equipment to move the world forward. Timken posted $3.5 billion in sales in 2020 and employs more than 17,000 people globally, operating from 42 countries. Timken is recognized among America’s Most Responsible Companies by Newsweek, the World’s Most Ethical Companies® by Ethisphere and America’s Best Employers by Forbes.

Media Relations:

Scott Schroeder

234.262.6420
[email protected]

Investor Relations:

Neil Frohnapple

234.262.2310
[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/timken-to-announce-first-quarter-2021-financial-results-on-april-28-301263474.html

SOURCE The Timken Company

MINNEAPOLIS, April 7, 2021 /PRNewswire/ — Target^® Corporation (NYSE:TGT) today announced a commitment to spend more than $2 billion with Black-owned businesses by the end of 2025. Target is pledging to add products across its multi-category assortment from more than 500 Black-owned businesses and engage more Black-owned companies to enhance its retail operations and shopping experience. In addition to spending more with Black-owned companies, Target is introducing new resources to help its Black-owned vendors grow and successfully scale their businesses in mass retail.

“We have a rich history of working with diverse businesses, but there’s more we can do to spark change across the retail industry, support the Black community and ensure Black guests feel welcomed and represented when they shop at Target,” said Christina Hennington, executive vice president and chief growth officer, Target. “The bold actions we’re announcing today reflect Target’s ongoing commitment to advance racial equity for the Black community. They also represent significant economic opportunity for hundreds of new Black-owned companies, who we look forward to doing business with for years to come.” 

Forward Founders
To further support Black-owned businesses, Target is establishing new resources, including a team that is dedicated to providing vendors with ongoing support and assisting them in growing and successfully scaling their businesses in mass retail. Building off the success of Target Accelerators, a portfolio of programs supporting entrepreneurs to drive innovation and instigate change, the company is introducing a new program called Forward Founders. This program will engage Black entrepreneurs earlier in their startup journey to help them navigate the critical stages of ideation, product development and scaling for mass retail. With increased access to subject matter experts and educational workshops earlier in the startup process, Forward Founders is designed to help Black-owned businesses increase their potential for long-term success in retail. 

Today’s $2 billion commitment builds upon Target’s progress to increase its network of diverse suppliers and accelerates its efforts to support even more Black-owned businesses. Through existing opportunities like Target Accelerators and events like the Black-Owned Business Vendor Fair, Target has brought in diverse businesses who have products ready for sale at retail. In some product categories, like beauty, Target has a strong representation of 50 Black-owned and Black-founded brands, with plans to continue to grow the assortment. 

To learn more about Target’s work with diverse suppliers, or to explore potential business and partnership opportunities with Target, interested businesses can visit Target’s supplier diversity page. 

Today’s announcement is a part of Target’s commitment to social justice and racial equity. Last year, Target established its Racial Equity Action and Change (REACH) committee composed of senior leaders from across the company who represent a diverse range of perspectives and expertise and guide the retailer’s efforts to engage in the fight to end systemic racism in the U.S. and drive lasting impact for the Black community. This investment builds upon Target’s previous commitments, including increasing Target’s representation of Black team members by 20% over the next three years and committing $10 million from Target and the Target Foundation to support nonprofit partners focused on addressing the systemic and structural barriers facing Black communities. 

Miscellaneous
Statements in this release regarding the company’s planned spending, merchandise assortment and support resources are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause the company’s actions to differ materially. The most important risks and uncertainties are described in Item 1A of the company’s Form 10-K for the fiscal year ended Jan. 30, 2021. 

Forward-looking statements speak only as of the date they are made, and the company does not undertake any obligation to update any forward-looking statement.

Additional details on Target’s commitment can be found on A Bullseye View.  

About Target 

Minneapolis-based Target Corporation (NYSE: TGT) serves guests at more than 1,900 stores and at Target.com. Since 1946, Target has given 5% of its profit to communities, which today equals millions of dollars a week. For the latest store count or more information, visit Target.com/Pressroom. For a behind-the-scenes look at Target, visit Target.com/abullseyeview or follow @TargetNews on Twitter.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/target-commits-to-spending-more-than-2-billion-with-black-owned-businesses-by-2025-301263970.html

SOURCE Target Corporation

VANCOUVER, BC, April 7, 2021 /PRNewswire/ – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company, announces that it will begin its Northeast rollout by mid April 2021, through “Big Y” World Class Markets, out of Springfield Massachusetts. Else’s Plant-Based Nutrition for Toddlers will be available for purchase in all 71 Big Y grocery stores.

“Launching with Big Y represents another exciting milestone for Else,” said Hamutal Yitzhak, Else CEO and Co-Founder. “The northeast population size is paramount to the growth of our brand. Big Y’s large-format shelves and health-minded shoppers represent an opening into the progressive New England customer-base. We are eager to bring real, whole food-based, clean label solutions to families in this region,” she added.

About Big Y

Big Y is one of the largest independently owned supermarket chains in New England, and it employs over 12,000 people. In 2020 Big Y was the 210th-largest private company in the United States, according to that year’s Forbes magazine “500 Largest Private Companies” list. As of October 2020, Big Y operates 71 supermarkets in Massachusetts and Connecticut;^[1][3] many of which are located in the metropolitan areas of Springfield, Worcester, Greater Boston, and Hartford. In addition to its traditional supermarkets, Big Y owns and operates two specialty markets: Table & Vine, a large specialty liquor and wine store in West Springfield; and the Fresh Acres Market, a concept mixing an open-air-style farmers’ market with upscale food choices, in Springfield. Big Y also operated two standalone pharmacies in Springfield and Wilbraham before eventually folding them into the pharmacies located in its nearby stores.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board  members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents.  Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

View original content to download multimedia:http://www.prnewswire.com/news-releases/else-to-launch-product-rollout-to-big-y-stores-in-april-301263657.html

SOURCE Else Nutrition Holdings Inc.

Contract awarded for products that bring improvement to health care industry

QUEBEC CITY, April 7, 2021 /CNW Telbec/ – OpSens Inc. (“OpSens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company, announced today it has been awarded an Innovative Technology  contract from Vizient, Inc., the largest member-driven health care performance improvement company in the U.S. The contract was awarded based on the recommendation of OptoWire III, a guidewire to diagnose and treat coronary disease, by hospital experts who serve on one of Vizient’s member-led councils.

Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology Program. Vizient member-led councils identify technologies that have the potential to enhance clinical care, patient safety, health care worker safety or improve business operations of health care organizations.

The OpSens OptoWire III is a modern pressure guidewire designed for contemporary clinical practice to diagnose, treat, and confirm results in coronary arteries. The OptoWire III allows navigation through complex anatomies, delivery of a stent without guidewire exchange, choices among different hyperemic and resting indices to assess coronary physiology, and confirmation of treatment with easy and reliable post-PCI measurements. The accuracy of the device, or absence of drift, and the possibility to use a single wire for the full procedure, can cut time and costs from the procedure and provides confidence in the diagnosis with consistent and repeatable measurements.

Louis Laflamme, President and Chief Executive Officer of OpSens, commented, “We are delighted to have been awarded a contract with Vizient. We are honored to be rewarded for the innovation we are bringing with the OptoWire III. Working with hospital systems has been a key initiative within OpSens and we are excited to be in the position to serve the numerous Vizient members through this contract.”

“Hospitals and providers are looking for innovations that offer unique benefit over other products available on the market today. Our member council determined this technology met the criteria to be awarded with the Innovative Technology contract. Congratulations to OpSens on receiving this status,” said Debbie Archer, director of procurement and Vizient Innovative Technology Program leader.

Coronary artery disease is the blockage or narrowing (stenosis) of the arteries that supply blood to the heart muscle, often due to the buildup of fatty plaque inside the arteries, which may cause heart attacks. Several studies, such as the FAME Study, showed that when Fractional Flow Reserve (FFR) is used prior to percutaneous coronary intervention (PCI), patients’ outcomes are improved with major adverse cardiac events significantly reduced.

The OptoWire III offers physicians several competitive advantages, including superior steerability, reliability in coronary physiologic assessments, and the ability to use a single guidewire for the entire procedure, saving physicians and staff costs and time. Since OptoWire’s approval in 2015, more than 100,000 patients have been evaluated or treated with this system.

About OpSens Inc. (www.OpSens.com or www.OpSensmedical.com)

OpSens focuses mainly on coronary physiology products in interventional cardiology. OpSens offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 100,000 patients in more than 30 countries. It is approved for sale in the United States, European Union, Japan, and Canada.

OpSens is also involved in industrial activities in developing, manufacturing, and installing innovative fiber optic sensing solutions for critical applications.

Forward-looking statements contained in this press release involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, and achievements of OpSens to be materially different from any future results, performance or achievements expressed or implied by the said forward-looking statements.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.

SOURCE OPSENS Inc.

LAVAL, Quebec, April 7, 2021 /PRNewswire/ — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) today announced it will reduce debt by $100 million through the redemption of outstanding senior secured notes, using cash generated from operations.

Bausch Health will redeem $100 million aggregate principal amount of its outstanding 7.00% Senior Secured Notes due 2024, CUSIP Nos. 91911K AK8, C94143 AK7 (the “Notes”) on May 7, 2021. The Company previously redeemed a total of $200M aggregate principal amount of the Notes in March 2021.

The Company will issue today an irrevocable notice of redemption for the Notes and a copy will be issued to the record holders of such Notes. Nothing contained herein shall constitute a notice of redemption of the Notes. Payment of the redemption price and surrender of the Notes for redemption will be made through the facilities of the Depository Trust Company in accordance with the applicable procedures of the Depository Trust Company. The name and address of the paying agent are as follows: The Bank of New York Mellon; 111 Sanders Creek Parkway, East Syracuse, N.Y. 13057; Attn: Redemption Unit; Tel: 800-254-2826.

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people’s lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.

Caution Regarding Forward-Looking Information and “Safe Harbor” Statement
This news release may contain forward-looking statements, including, but not limited to, the redemption of the Notes. Forward-looking statements may generally be identified by the use of the words “anticipates,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “estimates,” “potential,” “target,” or “continue” and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in the Company’s most recent annual and quarterly reports and detailed from time to time in the Company’s other filings with the Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, and the fear of that pandemic and its potential effects, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on the Company, including but not limited to its supply chain, third-party suppliers, project development timelines, employee base, liquidity, stock price, financial condition and costs (which may increase) and revenue and margins (both of which may decrease). Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/bausch-health-to-reduce-debt-by-100-million-using-cash-generated-from-operations-301263530.html

SOURCE Bausch Health Companies Inc.

NEW YORK, April 7, 2021 /PRNewswire/ — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Tiger Brokers, a leading stock brokerage in Asia that allows customers to buy and sell stocks from all over the world, as a new distributor of OTC Markets’ Real-Time Level 2+ Quotes.

With this agreement, Tiger Broker’s clients now have convenient access to real-time depth of book pricing for OTCQX®, OTCQB® and Pink® market securities to assist in trading and investment decision-making. This agreement increases the availability of data on OTC equity securities to Tiger Broker’s platform of investors.

“We are pleased that Tiger Broker’s trading platform now provides customers the benefit of additional access to real-time data on over 11,000 OTCQX, OTCQB and Pink securities,” said Matthew Fuchs, Executive Vice President of Market Data and Strategy at OTC Markets Group. “Providing key real-time data points to analyze, value and trade the expansive roster of OTC equities increases subscriber options and further supports Tiger Broker’s mission of leveraging technology to encourage participation in the financial markets.”

“At Tiger Brokers, we are dedicated to providing the best trading experience to our customers,” stated Mr. Wu Tianhua, the company’s founder and CEO. “Our alliance with OTC Markets Group will give our customers an edge with detailed insights into the OTC market, assisting them to make more informed trading decisions.”

OTC Markets Group’s Market Data provides mission-critical data to broker-dealers, compliance, and risk management teams.  As the primary market operator, we deliver the most comprehensive, contextual, real-time and analytical data on OTCQX, OTCQB and Pink securities. 

For more about OTC Markets Group’s market data products, including connectivity information, visit https://www.otcmarkets.com/market-data/overview.  

To contact OTC Markets Market Data, call +1 (212) 220-2166 or e-mail [email protected].    

About Tiger Brokers
Founded in 2014, Tiger Brokers (NASDAQ:TIGR) is a leading global online broker. Tiger uses its next generation technology to enable clients to trade a wide range of securities across multiple global markets and currencies. Clients may use Tiger’s flagship mobile trading APP, Tiger Trade, to trade equities in The U.S., Hong Kong, Singapore, and Australia as well as futures, options, and funds. Tiger Brokers has offices in Singapore, New York, Beijing, Auckland, and Sydney and employees over 800 people. The firm presently holds brokerage licenses in Singapore, The U.S., New Zealand, and Australia.

To learn more about the company, please go to www.itiger.com

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for over 11,000 U.S. and global securities.  Through OTC Link® ATS and OTC Link ECN, we connect a diverse network of broker-dealers that provide liquidity and execution services.  We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.

OTC Link ATS and OTC Link ECN are SEC regulated ATSs, operated by OTC Link LLC, member FINRA/SIPC.

Subscribe to the OTC Markets RSS Feed
 

Media Contact:

OTC Markets Group Inc., +1 (212) 896-4428, [email protected]

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/otc-markets-group-adds-tiger-brokers-as-distributor-of-real-time-level-2-quotes-301262706.html

SOURCE OTC Markets Group Inc.

ST. PAUL, Minn., April 7, 2021 /PRNewswire/ — CHS Inc. (NASDAQ: CHSCP), the nation’s leading agribusiness cooperative, today released results for its fiscal second quarter ended Feb. 28, 2021. The company reported a net loss of $38.2 million versus net income of $125.4 million in the same quarter in fiscal 2020. Significant year-over-year earnings increases in Ag and Nitrogen Production segments and Corporate and Other businesses were offset primarily by ongoing COVID-19 pandemic-related impacts in Energy.

“Improved trade relations between the United States and foreign trade partners combined with our operating efficiency initiatives led to record grain and oilseed volume increases and continued price gains, significantly improving our Ag segment earnings over the prior year,” said Jay Debertin, president and CEO of CHS Inc. “Additionally, favorable growing conditions and overall strength in agriculture, helped drive demand for crop inputs, including crop nutrients and crop protection products and services.

“Our Energy segment, while showing improvement over the previous quarter, continues to experience unfavorable refined fuels market conditions related to the COVID-19 pandemic and exceptionally higher costs for renewable energy credits. These factors resulted in volume and margin declines that significantly reduced earnings compared to the prior year.”

Fiscal 2021 second-quarter results reflect:

• Revenues of $8.3 billion versus $6.6 billion in fiscal 2020 second quarter, a 26.1% increase.
• Energy segment impacts that include:
• Continued low refining margins stemming from COVID-19-impacts on global energy demand.
• Exceptionally high costs of renewable energy credits, which decreased margins.
• Decreased propane margins and volumes due to warm winter weather conditions across the CHS trade territory during most of the fiscal 2021 second quarter.
• Modest improvements over fiscal 2021 first quarter as volumes and margins began to rebound.
• Ag segment impacts that include:
• Favorable weather conditions and improved relations between the U.S. and foreign trade partners, including China, that increased volumes of grain and oilseed commodities as well as feed and farm supplies.
• Higher margins for certain agricultural products, including processing and food ingredients, which improved because of soybean crush strength.
• Enterprisewide initiatives that include:
• Focused cost-reduction initiatives launched in fiscal 2021 that helped reduce marketing, general and administrative costs.
• COVID-19-related working arrangements and increased hygiene and infection-control processes to mitigate risk and support business continuity – all CHS operations were deemed to be essential infrastructure industries by federal and state governments.

For the six-month period ending Feb. 28, 2021, CHS reported net income of $31.4 million versus $303.3 million for the same period in fiscal 2020. Revenues for the first six months of fiscal 2021 rose to $17.0 billion, a $2.8 billion, or 19.8%, increase from $14.2 billion in the same period the previous year.

“I am encouraged by the resilience of our employees and their commitment to owners in what continues to be a challenging operating environment,” said Debertin. “We are cautiously optimistic about the rollout of COVID-19 vaccines and other progress being made in response to the pandemic in the U.S. and around the world and the potential impact on our domestic and global businesses.

“As we look ahead to the second half of fiscal 2021, we remain committed to protecting the financial health of CHS, adding efficiency throughout our enterprise to benefit owners and customers, and caring for those who depend on us as we continue creating connections to empower agriculture.”

CHS Inc. (www.chsinc.com) is a leading global agribusiness owned by farmers, ranchers and cooperatives across the United States. Diversified in energy, agronomy, grains and foods, CHS is committed to creating connections to empower agriculture, helping its farmer-owners, customers and other stakeholders grow their businesses through its domestic and global operations. CHS supplies energy, crop nutrients, seed, crop protection products, grain marketing services, production and agricultural services, animal nutrition products, foods and food ingredients, and risk management services. The company operates petroleum refineries and pipelines and manufactures, markets and distributes Cenex^® brand refined fuels, lubricants, propane and renewable energy products.

This document and other CHS Inc. publicly available documents contain, and CHS officers and representatives may from time to time make, “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Report Act of 1995. Forward-looking statements can be identified by words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on CHS current beliefs, expectations and assumptions regarding the future of its businesses, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of CHS control. CHS actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements. Important factors that could cause CHS actual results and financial condition to differ materially from those indicated in the forward-looking statements are discussed or identified in CHS filings made with the U.S. Securities and Exchange Commission, including in the “Risk Factors” discussion in Item 1A of CHS Annual Report on Form 10-K for the fiscal year ended August 31, 2020. Any forward-looking statements made by CHS in this document are based only on information currently available to CHS and speak only as of the date on which the statement is made. CHS undertakes no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise except as required by applicable law.

 

View original content:http://www.prnewswire.com/news-releases/chs-reports-fiscal-2021-second-quarter-results-301263997.html

SOURCE CHS Inc.

REHOVOT, Israel, April 7, 2021 /PRNewswire/ — Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company today announced that it will hold virtual investor and analyst days, in both Hebrew and English, via Zoom webinars.

The meetings will feature key-note presentations from Evogene’s CEO, Ofer Haviv, and the CEOs of Evogene group subsidiaries Biomica, Canonic, AgPlenus, and Lavie Bio, followed by a question and answer session.

• The Hebrew language event will be held on Monday, April 19, 2021 at 4pm IST or 9am ET. To register for this event, please visit the link:
  https://zoom.us/webinar/register/WN_MpdKOdKeTvqyR6LDbpJlCQ 
• The English language event will be held on Wednesday, April 21, 2021 at 4pm IST or 9am ET. To register for this event, please visit the link:
  https://zoom.us/webinar/register/WN_k8B2V0g_R9e1xYv5WIpt6A 

 

Questions to the speakers may be sent in advance of the event via the registration link or to [email protected] or may be sent via the Question and Answer link in the zoom webinar during the event.

About Evogene Ltd.:

Evogene (NASDAQ: EVGN), (TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform.  The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements.  Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ltd.

 

View original content:http://www.prnewswire.com/news-releases/evogene-to-hold-virtual-investor–analyst-days-301263905.html

SOURCE Evogene

LONDON, ON, April 7, 2021 /PRNewswire/ – VersaBank (“VersaBank” or the “Bank”) (TSX: VB), a leader in digital banking and cyber security solutions, today announced that it has received the following investment-grade credit ratings from Egan-Jones Ratings Company, a US Nationally Recognized Statistical Rating Organization (NRSRO) and US National Association of Insurance Commissioners (NAIC)-recognized Credit Rating Provider:

• “A” rating for the Bank overall; and,
• “A-” rating for the current subordinated debt issue up to US$100 million.

VersaBank’s overall “A” credit rating is comparable to that of several of the “Big Six” Canadian Schedule I Banks.

“This is a truly transformational event for VersaBank that will significantly expand our universe of depositors and open up a new, low-risk lending channel, providing the opportunity to further accelerate our growth by means that were not previously available to us,” said David Taylor, President and Chief Executive Officer, VersaBank.  “Moreover, the Bank’s investment-grade ratings are an external affirmation of our low-risk digital banking model, which is a fundamental component of our ability to drive earnings growth and shareholder value.”

“Importantly, the “A-” investment-grade rating for VersaBank’s subordinated debt provides the Bank with a new option for significantly lower-cost, non-dilutive, tax efficient capital that was previously not available to us to fuel our growth – especially beneficial during this current period of record loan growth.  These new ratings are especially valuable as we explore the potential to launch our innovative digital banking services in new geographic markets beyond Canada, where we see significant unmet needs similar to those that have driven the Bank’s strong, steady growth.”

VersaBank’s
Overall “A” Rating Enables New Low-Cost Deposit Channel, Significantly Expanding Universe of Depositors in Canada and the U.S.

The overall “A” rating for VersaBank by a National Association of Insurance Commissioners (NAIC)-recognized ratings agency significantly expands VersaBank’s universe of potential depositors, allowing the Bank to offer a very attractive deposit alternative to institutions such as insurance companies and named municipalities, among others, in Canada and internationally, who typically hold deposits for longer terms and are restricted to holding deposits with investment-grade rated financial institutions.

“The foundation of VersaBank’s low-risk, superior profitability proposition is our ability to source low-cost deposits, enabling us to achieve industry leading net interest margins,” said Mr. Taylor. “We recently achieved a new record low for its cost of funds at 1.34% and the Bank’s new investment-grade credit rating now enables large, long-term depositors, providing a significant additional source of low-cost funds.”

ABOUT VERSABANK

VersaBank is a Canadian Schedule I chartered bank with a difference. VersaBank became the world’s first fully digital financial institution when it adopted its highly efficient business-to-business model using its proprietary state-of-the art financial technology to profitably address underserved segments of the Canadian banking market in the pursuit of superior net interest margins while mitigating risk. VersaBank obtains all of its deposits and provides the majority of its loans and leases electronically, with innovative deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, VersaBank established wholly owned, Washington, DC-based subsidiary, DRT Cyber Inc. to pursue significant large-market opportunities in cyber security and develop innovative solutions to address the rapidly growing volume of cyber threats challenging financial institutions, multi-national corporations and government entities on a daily basis.

VersaBank’s Common Shares trade on the Toronto Stock Exchange under the symbol VB and its Series 1 Preferred Shares and Series 3 Preferred Shares trade under the symbols VB.PR.A and VB.PR.B respectively.

Visit our website at: www.versabank.com

Follow VersaBank on Facebook, Instagram, LinkedIn and Twitter.

View original content to download multimedia:http://www.prnewswire.com/news-releases/versabank-receives-investment-grade-credit-ratings-a-overall-and-a–sub-debt-ratings-transform-low-cost-deposit-opportunities-301263828.html

SOURCE VersaBank